Healthcare -
Biotechnology - NASDAQ - US
$ 0.6581
-0.903 %
$ 83 M
Market Cap
-0.63
P/E
KPTI - CAPITAL EXPENDITURES
Capital Expenditures KPTI - Karyopharm Therapeutics Inc.
0
LAST VALUE
41.42%
2 YEAR CAGR
14.87%
5 YEAR CAGR
7.18%
10 YEAR CAGR